Островская С. С., Герасимчук П. Г.

БИОЛОГИЧЕСКИЕ АСПЕКТЫ СВЯЗИ СЕРДЕЧНО-СОСУДИСТЫХ ЗАБОЛЕВАНИЙ И ТКАНЕЙ ПАРАДОНТА


Об авторе:

Островская С. С., Герасимчук П. Г.

Рубрика:

ОБЗОРЫ ЛИТЕРАТУРЫ

Тип статьи:

Научная статья.

Аннотация:

Связь парадонтита с риском развития сердечно-сосудистых заболеваний рассматривается как этиопатогенный фактор. В результате дисбактериоза оральной микробиоты развивается низкосортное системное воспаление, которое может быть причиной развития сердечно-сосудистых заболеваний. В этих процессах участвуют как прямые, так и косвенные факторы. Бактеримия и эндотоксемия в сочетании с иммунной дисфункцией провоцируют проатерогенные реакции. Токсическое воздействие и системные реакции антител являются медиаторами, связывающими оральный дисбактериоз с повышенным риском сердечнососудистых заболеваний.

Ключевые слова:

парадонтит, оральный дисбактериоз, сердечно-сосудистые заболевания

Список цитируемой литературы:

  1. Pietiäinen M, Liljestrand JM, Kopra E, Pussinen PJ. Mediators between oral dysbiosis and cardiovascular diseases. Eur Journal of Oral Sci. 2018;126(1):26-36.
  2. Chan W, Bosch JA, Phillips AC, Chin SH, Antonysunil A, Inston N, et al. The Associations of Endotoxemia With Systemic Inflammation, Endothelial Activation, and Cardiovascular Outcome in Kidney Transplantation. Journal of Ren Nutr. 2018;28(1):13-27.
  3. Kinane DF, Stathopoulou PG, Papapanou PN. Periodontal diseases. Nat Rev Dis Primers. 2017;22(3):17038.
  4. Ketelhuth DF, Hansson GK. Adaptive response of T and B cells in atherosclerosis. Circ Res. 2016;118(4):668-78.
  5. Lockhart PB, Bolger AF, Papapanou PN, Osinbowale O, Trevisan M, Levison ME, et al. Periodontal disease and atherosclerotic vascular disease: does the evidence support an independent association?: a scientific statement from the American Heart Association. Circulation. 2012;125(20):2520-44.
  6. Atarbashi-Moghadam F, Havaei SR, Havaei SA, Hosseini NS, Behdadmehr G, Atarbashi-Moghadam S. Periopathogens in atherosclerotic plaques of patients with both cardiovascular disease and chronic periodontitis. ARYA Atheroscler. 2018;14(2):53-7.
  7. Koren O, Spor A, Felin J, Fak F, Stombaugh J, Tremaroli V, et al. Human oral, gut, and plaque microbiota in patients with atherosclerosis. Proc Natl Acad Sci USA. 2011;108(1):4592-8.
  8. Kinane DF, Galicia JC, Gorr SU, Stathopoulou PG, Benakanakere M. P. gingivalis interactions with epithelial cells. Front Biosci. 2008;13:966-84.
  9. Stearns JC, Lynch MD, Senadheera DB, Tenenbaum HC, Goldberg MB, Cvitkovitch DG, et al. Bacterial biogeography of the human digestive tract. Sci Rep. 2011;1:170-6.
  10. Liljestrand JM, Paju S, Buhlin K, Persson GR, Sarna S, Nieminen MS, et al. Lipopolysaccharide, a possible molecular mediator between periodontitis and coronary artery disease. Journal of Clin Periodontol. 2017;44(8):784-92.
  11. Xu X, He J, Xue J, Wang Y, Li K, Zhang K, et al. Oral cavity contains distinct niches with dynamic microbial communities. Environ Microbiol. 2015;17(3):699-710.
  12. Pussinen PJ, Tuomisto K, Jousilahti P, Havulinna AS, Sundvall J, Salomaa V. Endotoxemia, immune response to periodontal pathogens, and systemic inflammation associate with incident cardiovascular disease events. Arterioscler Thromb Vasc Biol. 2007;27(6):1433-9.
  13. Liljestrand JM. Systemic exposure to oral infections: a cardiometabolic risk. Dissertations of the University of Helsinki 60/2017. PhD thesis.
  14. Andriankaja O, Trevisan M, Falkner K, Dorn J, Hovey K, Sarikonda S, et al. Association between periodontal pathogens and risk of nonfatal myocardial infarction. Community Dent Oral Epidemiol. 2011;39:177-85.
  15. Fåk F, Tremaroli V, Bergström G, Bäckhed F. Oral microbiota in patients with atherosclerosis. Atherosclerosis. 2015;243(2):573-8.
  16. Nakajima M, Arimatsu K, Kato T, Matsuda Y, Minagawa T, Takahashi N, et al. Oral administration of P. gingivalis induces dysbiosis of gut microbiota and impaired barrier function leading to dissemination of Enterobacteria to the liver. PLoS ONE. 2015;10(7):e0134234.
  17. Kallio KA, Hätönen KA, Lehto M, Salomaa V, Männistö S, Pussinen PJ. Endotoxemia, nutrition, and cardiometabolic disorders. Acta Diabetol. 2015;52(2):395-404.
  18. Buhlin K, Holmer J, Gustafsson A, Hörkkö S, Pockley AG, Johansson A, et al. Association of periodontitis with persistent, pro-atherogenic antibody responses. Journal of Clin Periodontol. 2015;42(11):1006-14.
  19. Metzler B, Schett G, Kleindienst R, van der Zee R, Ottenhoff T, Hajeer A, et al. Epitope specificity of anti-heat shock protein 65/60 serum antibodies in atherosclerosis. Arterioscler Thromb Vasc Biol. 1997;17:536-41.
  20. Wick G, Jakic B, Buszko M, Wick MC, Grundtman C. The role of heat shock proteins in atherosclerosis. Nat Rev Cardiol. 2014;11:516-29.
  21. Schenkein HA, Loos BG. Inflammatory mechanisms linking periodontal diseases to cardiovascular diseases. Journal of Clin Periodontol. 2013;40(14):51-69.
  22. Holmlund A, Hedin M, Pussinen PJ, Lerner UH, Lind L. Porphyromonas gingivalis (Pg) a possible link between impaired oral health and acute myocardial infarction. Int Journal of Cardiol. 2011;148:148-53.
  23. Hyvärinen K, Mäntylä P, Buhlin K, Paju S, Nieminen MS, Sinisalo J. A common periodontal pathogen has an adverse association with both acute and stable coronary artery disease. Atherosclerosis. 2012;223(2):478-84.
  24. Colhoun HM, Slaney JM, Rubens MB, Fuller JH, Sheiham A, Curtis MA. Antibodies to periodontal pathogens and coronary artery calcification in type 1 diabetic and nondiabetic subjects. Journal of Periodontal Res. 2008;43:103-10.
  25. Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler Thromb Vasc Biol. 2003;23:1250-4.
  26. Liljestrand JM, Paju S, Pietiäinen M, Buhlin K, Persson GR, Nieminen MS, et al. Pussinen PJ. Immunologic burden links periodontitis to acute coronary syndrome. Atherosclerosis. 2018;268:177-84.
  27. Hayes AF, Rockwood NJ. Regression-based statistical mediation and moderation analysis in clinical research: observations, recommendations, and implementation. Behav Res Ther. 2017;98:39-57.
  28. Palm F, Pussinen PJ, Aigner A, Becher H, Buggle F, Bauer MF, et al. Association between infectious burden, socioeconomic status, and ischemic stroke. Atherosclerosis. 2016;254:117-23.
  29. Jia R, Kurita-Ochiai T, Oguchi S, Yamamoto M. Periodontal pathogen accelerates lipid peroxidation and atherosclerosis. Journal of Dent Res. 2013;92:247-52.

Публикация статьи:

«Вестник проблем биологии и медицины» Выпуск 4 Том 2 (147), 2018 год, 58-61 страницы, код УДК 616.314.17-002:616.1:57.02-021.462

DOI: